MedTrace Logo

Postoperative Diet With Hyperproteic Supplement Versus a Supplement With Imunonutrients, in Colorectal Cancer Surgery

NCT04059731 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2019-08-16

No results posted yet for this study

Summary

The study is a randomized, multicentric, double-blind, controlled with active comparator, parallel groups trial, to demonstrate the non-inferiority in efficacy and therapeutic safety of the postoperative diet with oligomeric-hyperprotéic-normocaloric supplement (group 1) versus a supplement with imunonutrients (group 2), in a multimodal rehabilitation regimen (ERAS) of colorectal surgery for colon cancer and that arrive at surgery in a normal nutritional state or without any intervention on their nutritional status, according to the scale Malnutrition Screening Tool (MST).

Conditions

  • Nutrition Related Neoplasm/Cancer
  • Colorectal Cancer
  • Surgery--Complications
  • Site Infection
  • Nutrition Support

Interventions

DIETARY_SUPPLEMENT

Nutrition supplement

Administration twice a day of Survimed OPD or Impact/Atempero depending on arm assigned during 5 postoperative days

Sponsors & Collaborators

  • Hospital General Universitario Reina Sofía de Murcia

    lead OTHER

Principal Investigators

  • Jorge Alejandro Benavides Buleje, PhD · Hospital General Universitario Reina Sofía

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-20
Primary Completion
2019-08-10
Completion
2020-06-20

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04059731 on ClinicalTrials.gov